Juvenile Arthritis - Factors Linked To Better Medication Response | HEADLINE NEWS ONLINE | LATEST NEWS AND ARTICLES FROM ALL OVER THE WORLD | HEADLINE NEWS

Links shared publicly online about this topic.

0
total visits

Juvenile Arthritis - Factors Linked To Better Medication Response | HEADLINE NEWS ONLINE | LATEST NEWS AND ARTICLES FROM ALL OVER THE WORLD | HEADLINE NEWS

According to JAMA, one third of patients with juvenile idiopathic arthritis (JIA) starting receiving etanercept treatment demonstrated excellent responses. Etanercept, approved 10 years ago by the U.S. FDA and European Agency for the treatment of JIA, is linked to younger age at the onset of JIA, low measures of disability at study entry and fewer disease-modifying antirheumatic drug use before starting etanercept therapy. The study will be presented at the American College of Rheumatology/Assoc

View full resource at headlinenewsonline.com

Tags: Arthritis, Rheumatoid Arthritis Medication, Juvenile Rheumatoid Arthritis, Drug, Children's Health, Enbrel, News